Labcorp to acquire Toxikon
Labcorp a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Toxikon , a contract research organization delivering best-in-class nonclinical testing services. Once completed, the transaction will create a strategic footprint for Labcorp to partner with pharmaceutical and biotechnology clients in the Boston, Mass., area and bolster its strong nonclinical development portfolio.